Featured Post

2 mins read

FDA Approves Opzelura (Ruxolitinib) Cream for Vitiligo in Patients Aged 12 Years and Older

On July 19, 2022, the FDA approved Opzelura (ruxolitinib), the first and only topical treatment for non-segmental vitiligo in adult […]

ikrisuser
July 28, 2022
2 mins read

Named Patient Program (NPP): An Exceptional Importation Regimes of Pharmaceuticals

Named Patient Program (NPP); an Exceptional Importation Regime of Pharmaceuticals that provides controlled access to drugs in response to requests […]

ikrisuser
July 22, 2022
3 mins read

Ghana Marburg Virus: WHO Ready To Control The Outbreak With A Death Rate Of 88%

World Health Organization (WHO): a specialized agency of the United Nations, which is responsible for international public health, has said […]

ikrisuser
July 15, 2022
2 mins read

COVID-19 Update: FDA Authorizes Pharmacists to Prescribe COVID Antiviral Pills Paxlovid

All the patients who test positive for an infectious disease Coronavirus caused by the SARS-CoV-2 virus can now get the […]

ikrisuser
July 13, 2022
2 mins read

World Health Organization Publishes 3 Key New Recommendations on Hepatitis C Infection

On 24 June 2022, World Health Organization published 3 key new recommendations on hepatitis C infection during a joint WHO-EASL-CDC […]

ikrisuser
July 8, 2022
2 mins read

Reference Listed Drug: Essential for generic drug development

As per FDA, A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared […]

ikrisuser
July 5, 2022
2 mins read

Achondroplasia: Symptoms and Treatment

The word “Achondroplasia” itself means without cartilage formation, and this genetic disorder is a form of short-limbed dwarfism. Achondroplasia is […]

ikrisuser
June 30, 2022
2 mins read

COVID-19 Vaccines: FDA Authorizes Moderna & Pfizer-BioNTech for Children Aged 6 Months and Above

On June 17, 2022, the US Food and Drug Administration (FDA) authorized emergency use of COVID-19 vaccines named Moderna and […]

ikrisuser
June 27, 2022
3 mins read

Olumiant (Baricitinib): A New Medicine in The Town for Alopecia Areata

On June 13, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved oral tablets of Olumiant (baricitinib) […]

ikrisuser
June 21, 2022
2 mins read

Dostralimab: Cancer vanishing drug for the first time in history

The drug Dostarlimab can become a miracle medicine for cancer patients. In a recent small clinical trial, for the first […]

ikrisuser
June 13, 2022
We Offer You

Partnership

We love to partner with brands and products that we believe in. If you feel that your company shares values and would benefit our readers, we would love to talk about working together.

Learn More